VIP Leaf (Vertical Indoor Protein from Leaf)

VIP Leaf（来自叶子的垂直室内蛋白质）

• 批准号: 10050842
• 金额: $ 93.97万
• 依托单位: VERTICAL FUTURE LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10050842
• 关键词: VIP; Leaf; Vertical; Indoor; Protein

Current consumption of meat is unsustainable for the planet and public health. Alternative protein sources are essential and **demand for plant-based protein is increasing**. Plant proteins used in UK food are mainly from imported soy and pea. The market is shifting away from soy due to deforestation and allergy concerns, and UK pea protein production remains low (4% arable land) due to perceptions of high-risk, low-yield and unprofitability. **CEA offers an alternative production space** and the advantage of enabling **new crops** to be grown in the UK that are incompatible with our climate, allowing a better diversification of our food-protein-sources.CEA systems are not yet commercially used in the production of plant-derived proteins, yet offer huge potential to **localise protein production** to food manufacturing sites, **reduce reliance on imports** and enable low water-use/agrochemical-free production. The economics of plant protein production and the uptake in the UK are significantly better than insect protein (nearest competitor) due to no feed-to-food conversion loss. A number of leafy crops including spinach, sunflower shoots and amaranth leaf **contain \>20% protein**. Amaranth has high lysine content (high-value amino acid to the vegan protein market), as well as health-promoting vitamins, minerals and antioxidants. CEA offers economically viable production with short time to harvest, reduced resource use and reduced land footprint.Our project will access leaf-derived protein for the burgeoning alternative protein market. We will test new sources of leaf protein, as well as further develop varieties, production and downstream processing methods for amaranth to open up vertical farming to the alternative protein sector and enable localizing of protein production to sites of food manufacture. This work will help meet UK challenges of i) **Net Zero Carbon** by 2050 (landuse change - plant protein production requires far less land/kg than meat protein; CEA has high yield/m2 and doesn't require agricultural-quality land), ii) **tackling growing obesity** with associated NHS costs (consumption of plant protein is linked to improved health), and iii) **Green Recovery** (CEA enables reduced food-miles, low waste/environmental pollution).

目前的肉类消费对地球和公众健康来说是不可持续的。替代蛋白质来源至关重要，** 对植物蛋白质的需求正在增加 **。英国食品中使用的植物蛋白主要来自进口大豆和豌豆。由于森林砍伐和过敏问题，市场正在从大豆转向大豆，由于高风险、低产量和无利可图的看法，英国豌豆蛋白产量仍然很低（4%耕地）。**CEA提供了一个替代的生产空间 **，并使 ** 新作物 ** 能够在英国种植，这与我们的气候不相容，从而使我们的食物蛋白质来源更加多样化。CEA系统尚未在商业上用于植物源蛋白质的生产，但提供了巨大的潜力，将蛋白质生产 ** 本地化到食品制造场所，** 减少对进口的依赖 **，实现低用水/无农用化学品生产。在英国，植物蛋白生产和吸收的经济性明显优于昆虫蛋白（最接近的竞争对手），因为没有饲料到食物的转化损失。许多多叶作物，包括菠菜、向日葵芽和阿马兰斯叶 ** 含有>20%的蛋白质 **。阿马兰斯有高赖氨酸含量（高价值的氨基酸，素食蛋白市场），以及促进健康的维生素，矿物质和抗氧化剂。CEA提供经济可行的生产，收获时间短，减少资源使用和减少土地足迹。我们的项目将为新兴的替代蛋白市场获得叶源蛋白。我们将测试新的叶蛋白来源，并进一步开发阿马兰斯的品种、生产和下游加工方法，以向替代蛋白质行业开放垂直农业，并将蛋白质生产本地化到食品生产现场。这项工作将有助于英国在2050年前应对i）** 净零碳 ** 的挑战（土地使用变化-植物蛋白生产所需土地/公斤远远少于肉类蛋白; CEA具有高产量/m2，不需要农业质量的土地），ii）** 解决日益增长的肥胖 ** 与相关的NHS成本iii）** 绿色恢复 **（CEA能够减少食物里程、低浪费/环境污染）。